KEAP1 and head and neck squamous cell carcinoma: Thus, among recurrent and metastatic HNSCC patients, Keap1 mutations appear to be the most significant cause of clinical chemo-radio resistance (Fig. 7F) and are coupled with the activation of the Notch signaling pathway.